Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers
Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) ...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Pharmacy / Mustansiriyah University
2020-06-01
|
| Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/689 |
| _version_ | 1797223877995134976 |
|---|---|
| author | Hawkar Qadir Baiz Tavga Ahmed Aziz Dana Ahmed Sharif |
| author_facet | Hawkar Qadir Baiz Tavga Ahmed Aziz Dana Ahmed Sharif |
| author_sort | Hawkar Qadir Baiz |
| collection | DOAJ |
| description |
Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease.
Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD)
screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters.
Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters.
Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL.
|
| first_indexed | 2024-04-24T13:44:13Z |
| format | Article |
| id | doaj.art-a75180631366491e871a4c13a10b34fd |
| institution | Directory Open Access Journal |
| issn | 1815-0993 2959-183X |
| language | English |
| last_indexed | 2024-04-24T13:44:13Z |
| publishDate | 2020-06-01 |
| publisher | College of Pharmacy / Mustansiriyah University |
| record_format | Article |
| series | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| spelling | doaj.art-a75180631366491e871a4c13a10b34fd2024-04-04T07:00:46ZengCollege of Pharmacy / Mustansiriyah UniversityAl-Mustansiriyah Journal of Pharmaceutical Sciences1815-09932959-183X2020-06-0120110.32947/ajps.v20i1.689Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centersHawkar Qadir Baiz0Tavga Ahmed Aziz1Dana Ahmed Sharif2Department of Clinical Pharmacy, College of Pharmacy, University of Sulaimani, Sulaimani, IraqDepartment of Pharmacology and Toxicology, College of Pharmacy, University of SulaimaniDepartment of Internal Medicine, College of Medicine, University of Sulaimani, Sulaimani Iraq Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters. Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters. Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/689CKD-MBD, Pharmaceutical care, biochemical parameters, QoL, DRPs |
| spellingShingle | Hawkar Qadir Baiz Tavga Ahmed Aziz Dana Ahmed Sharif Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers Al-Mustansiriyah Journal of Pharmaceutical Sciences CKD-MBD, Pharmaceutical care, biochemical parameters, QoL, DRPs |
| title | Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers |
| title_full | Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers |
| title_fullStr | Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers |
| title_full_unstemmed | Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers |
| title_short | Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers |
| title_sort | potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease mineral bone disorder in sulaimani dialysis centers |
| topic | CKD-MBD, Pharmaceutical care, biochemical parameters, QoL, DRPs |
| url | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/689 |
| work_keys_str_mv | AT hawkarqadirbaiz potentialeffectofpharmaceuticalcaretoimproveoutcomesinpatientswithchronickidneydiseasemineralbonedisorderinsulaimanidialysiscenters AT tavgaahmedaziz potentialeffectofpharmaceuticalcaretoimproveoutcomesinpatientswithchronickidneydiseasemineralbonedisorderinsulaimanidialysiscenters AT danaahmedsharif potentialeffectofpharmaceuticalcaretoimproveoutcomesinpatientswithchronickidneydiseasemineralbonedisorderinsulaimanidialysiscenters |